According to Dr. Rodney Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc, Regents’ Professor at Texas State University System, the pandemic "reinforced the importance of preparedness, real-time surveillance, workforce resilience, supply chain security, and effective risk communication."

As healthcare organizations struggled to respond to rapidly changing conditions, infection prevention leaders found themselves helping guide decisions far beyond traditional surveillance activities. They became advisors on workforce protection, PPE utilization, public communication, supply shortages, emergency planning, and operational continuity.

The experience permanently changed executive expectations.

"IP leaders are now expected to build sustainable systems rather than temporary emergency responses," Rohde said.

Today, healthcare executives increasingly view infection prevention as a strategic business function rather than solely a regulatory requirement. Beyond reporting HAI metrics and preparing for surveys, infection prevention leaders are expected to help organizations anticipate risk, protect employees, maintain operational continuity, and support financial performance.

"IP leaders are expected to demonstrate measurable impacts on patient safety, operational continuity, workforce protection, regulatory compliance, and financial performance," Rohde explained.

That evolution has transformed infection prevention into a discipline that is deeply integrated into organizational decision-making.

"Infection prevention is no longer siloed,” he said. “It is integrated into organizational decision-making. I would like to believe that our partners in all facets of public health and healthcare are also working to make this a two-way street of communication."

Transparency has become another critical leadership skill. During periods of uncertainty, healthcare leaders must communicate clearly about what they know while remaining honest about what remains uncertain.

"Anyone associated with public health, healthcare, and/or research leadership must be transparent about what they understand 'in the moment' and how that truth may change hours, days, weeks, months, or years later," Rohde said.

Preparedness remains central to that mission. Rather than treating emergency preparedness as an annual exercise designed to satisfy regulatory requirements, Rohde believes readiness should be integrated into everyday operations.

Preparedness efforts should include routine drills, surveillance activities, supply inventory assessments, workforce cross-training, outbreak response planning, and regular executive reviews of emerging threats and vulnerabilities.

"Like any true preparedness drills, the activities should occasionally be unannounced for a more realistic response followed by debriefing of the team for lessons learned," he said.

The same strategic mindset increasingly applies to financial stewardship. As healthcare organizations continue to operate under budget constraints and margin pressures, infection prevention leaders are being asked to demonstrate measurable financial value in addition to clinical outcomes.

Rohde encourages teams to focus on "preventing healthcare-associated infections (HAIs), reducing outbreak-related disruptions, leveraging predictive analytics, and quantifying avoided costs associated with infections, readmissions, staff illness, and regulatory penalties."

For hospitals facing ongoing financial challenges, cost avoidance can be one of infection prevention's strongest business cases. Preventing a single HAI can eliminate substantial treatment costs, reduce patient length of stay, minimize readmissions, and lower exposure to reimbursement penalties.

Reducing hospital-acquired conditions requires a coordinated effort across multiple disciplines. Rohde recommends implementing evidence-based prevention bundles, strengthening surveillance programs, improving hand hygiene and environmental cleaning compliance, and rapidly identifying high-risk patients through multidisciplinary interventions.

Readmissions can likewise be reduced through better discharge planning, antimicrobial stewardship efforts, patient education, vaccination programs, follow-up care coordination, and earlier identification of post-discharge infection complications.

PPE strategy is another area where infection prevention and financial stewardship intersect. Rather than relying on crisis-driven purchasing decisions, Rohde recommends a more strategic and proactive approach.

Organizations should use "data-driven forecasting, standardized products where appropriate, supply diversification, stockpile management, and targeted PPE use based on risk assessments rather than crisis-driven purchasing."

The pandemic exposed vulnerabilities throughout healthcare supply chains, making contingency planning a priority for many organizations. According to Rohde, strong relationships with suppliers and regional partners remain essential.

"It is essential to plan for backup strategies often and with respect to your state or regional suppliers and contacts," he said.

As a result, collaboration between infection prevention and supply chain leaders has become increasingly important. Product selection, inventory management, supplier diversification, and preparedness planning all benefit when both groups work together to balance clinical requirements, operational needs, and financial realities.

Building buy-in across the organization

Even the strongest infection prevention strategies cannot succeed without support from the people responsible for implementing them.

Whether introducing new protocols, changing workflows, or deploying new technologies, infection prevention leaders must secure buy-in across departments and disciplines. That process requires more than simply telling people what to do. It requires helping employees understand why changes matter and how they contribute to both patient safety and organizational success.

When engaging physicians, Rohde recommends focusing on evidence and outcomes.

"Present clinically relevant data, demonstrate impacts on patient outcomes, engage physician champions, and align prevention efforts with quality and safety goals," he said.

Physician champions can be valuable allies because they help reinforce best practices among peers and connect infection prevention initiatives directly to patient care. While many of these principles can apply across healthcare, they are particularly effective when working with physicians whose primary focus is clinical outcomes.

Working with supply chain leaders requires a different conversation. Procurement teams evaluate decisions through the lens of product performance, availability, reliability, and cost effectiveness.

For that reason, Rohde encourages infection prevention teams to "develop collaborative forecasting models, evaluate product performance, monitor shortages, and ensure infection prevention requirements are incorporated into purchasing decisions."

Strong collaboration helps ensure products meet both clinical and operational needs while reducing the risk of disruption.

Nursing leadership remains another essential partner.

"Nursing leaders are critical implementation partners who drive compliance, reinforce best practices, support education, and identify frontline barriers to success," Rohde said.

Because nurses interact continuously with patients and interdisciplinary care teams, they frequently identify workflow challenges before they become larger operational problems. Their engagement is often essential to sustaining infection prevention initiatives over time.

Rohde also believes healthcare organizations should place greater emphasis on collaboration with laboratory professionals.

"I would also add the critical importance of alignment with one's medical laboratory professionals and the department," he said. "Laboratory professionals are critical to understanding the microbiology and other epidemiological aspects of particular pathogens and outbreaks related to IP and healthcare environments."

Laboratory teams provide the diagnostic information that powers surveillance programs, outbreak investigations, and evidence-based decision-making. Their expertise can help infection prevention leaders identify emerging threats sooner and develop more informed response strategies.

Of course, resistance to change remains an inevitable challenge.

New initiatives often compete with existing priorities, increase workloads, or require staff to alter familiar behaviors. When employees fail to see the purpose behind an initiative or struggle to observe tangible benefits, adoption can become difficult.

"Transparency and shared accountability are essential," Rohde said.

Organizations are more likely to achieve success when leaders clearly communicate objectives, explain the rationale behind changes, and demonstrate measurable outcomes.

It is equally important to manage initiative fatigue. Healthcare professionals already face a growing number of responsibilities, making careful prioritization critical.

To avoid overwhelming staff, Rohde recommends focusing on high-impact interventions, aligning projects with broader organizational priorities, eliminating redundant efforts, and maintaining consistent communication.

"Leadership needs to set the example and expectations consistently," he said.

Data can be particularly effective in sustaining engagement.

According to Rohde, "Dashboards, benchmarking, trend analyses, and unit-specific performance metrics help connect behaviors with patient outcomes and organizational performance."

When employees can see how individual actions contribute to organizational goals, they are more likely to remain engaged in improvement efforts.

Performance data also creates opportunities to recognize success.

"Celebrate the wins with everyone and reward those involved at all levels," Rohde said.

Acknowledging successful departments and frontline teams reinforces positive behaviors while helping establish infection prevention as a shared responsibility across the organization rather than the sole responsibility of a single department.

Demonstrating value and preparing for what comes next

As infection prevention leaders assume broader responsibilities, their ability to communicate value to executive leadership becomes increasingly important.

According to Rohde, one of the most effective approaches is focusing on risks that were avoided rather than simply reporting activities completed.

Organizations should quantify "prevented HAIs, outbreaks, regulatory citations, workforce exposures, reputational damage, and avoidable patient harm."

Whenever possible, those figures should be supplemented by predictive modeling and other analyses that estimate cost savings and health outcomes associated with prevention efforts.

Operational metrics can be equally compelling.

Rohde advises leaders to highlight "reduced bed closures, staffing shortages, procedure cancellations, supply interruptions, and outbreak-related operational slowdowns."

These types of outcomes often resonate strongly with executive leaders because they connect infection prevention efforts directly to organizational performance. Every avoided disruption helps preserve capacity, support revenue generation, improve access to care, and reduce strain on frontline staff.

Workforce efficiency presents another opportunity to demonstrate value.

According to Rohde, "automation, improved workflows, and prevention efforts reduce manual surveillance activities, outbreak response demands, and staff absenteeism."

These efficiencies allow infection prevention professionals to devote more time to strategic initiatives, trend analysis, and collaborative planning instead of constantly responding to preventable problems.

Financial reporting should similarly extend beyond avoided treatment costs.

Organizations can demonstrate value through reduced reimbursement penalties, fewer legal liabilities, lower overtime expenses, and avoided revenue losses associated with outbreak-related disruptions and healthcare-associated infections.

Looking ahead, Rohde sees several emerging challenges that healthcare organizations should monitor closely.

These include antimicrobial resistance, emerging pathogens, biofilm-related issues, climate-related infectious disease expansion, workforce shortages, and increasing diagnostic complexity.

To improve communication between laboratory and clinical teams, Rohde suggests some organizations may benefit from adding a Doctor of Clinical Laboratory Science (DCLS).

"It may be helpful to consider bringing on a DCLS to bridge communication between the laboratory testing and physician, IP, nursing, and EVS teams," he said.

Organizations should also avoid waiting until the next crisis arrives before investing in key capabilities.

"Invest in surveillance technology, workforce development, diagnostic readiness, preparedness planning, and cross-functional resilience strategies before the next crisis emerges," Rohde advised.

That preparedness extends directly to workforce sustainability.

Like much of healthcare, infection prevention continues to face challenges related to staffing, retention, and burnout. According to Rohde, flexible staffing models can help organizations improve resilience through cross-training, regional resource sharing, hybrid on-site and remote surveillance activities, surge staffing plans, and competency-based workforce development.

Developing future leaders is equally important.

Healthcare organizations should invest in mentorship programs, succession planning, leadership development opportunities, certification support, and interdisciplinary collaboration.

"This will need to include funding for continuing education at conferences and other vehicles to gain more IP and other types of credentials," Rohde said.

Technology can further reduce administrative burdens through automated surveillance systems, electronic health record integration, workflow automation, predictive analytics, and AI-assisted data review.

AI holds promise for identifying infection trends, detecting outbreaks earlier, automating portions of chart review, and supporting predictive risk modeling. However, Rohde cautions that organizations must remain mindful of issues involving data quality, algorithm bias, transparency, cybersecurity risks, and overreliance on automated outputs.

Like many healthcare leaders, he views AI as a tool that should augment, not replace, clinical expertise.

Ultimately, Rohde believes one of the most effective ways to strengthen workforce resilience is to make infection prevention everyone's responsibility.

Healthcare organizations should develop infection prevention competencies across nursing, environmental services, laboratory, respiratory therapy, and physician teams so prevention becomes embedded throughout the organization rather than concentrated within a small group of specialists.

At the same time, organizations should provide psychological support resources, workload-management strategies, peer-support programs, recovery time following major outbreaks, and leadership recognition of chronic workplace stressors.

Preparedness, collaboration, and shared ownership are recurring themes throughout Rohde's recommendations. By investing in surveillance, workforce resilience, emergency planning, and routine readiness exercises before the next crisis arrives, healthcare organizations can position themselves to protect patients, support staff, and maintain operational stability in an increasingly complex healthcare environment.